RPRX logo

RPRX

Royalty Pharma plc

$35.98
+$0.36(+1.01%)
81
Overall
100
Value
63
Tech
--
Quality
Market Cap
$20.98B
Volume
2.99M
52W Range
$24.05 - $38.00
Target Price
$44.33
Order:

Income Statement

MetricTrendChart
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$2.1B$2.3B$2.2B$2.4B$2.3B
Total Revenue
$2.1B$2.3B$2.2B$2.4B$2.3B
GROSS PROFIT
Gross Profit
$2.1B$2.3B$2.2B$2.4B$2.3B
OPERATING EXPENSES
Operating Expenses
$296.1M$405.9M$1.3B$301.7M$238.7M
Research & Development
$26.3M$200.1M$177.1M$52.0M$2.0M
Research Expense
$26.3M$200.1M$177.1M$52.0M$2.0M
Selling, General & Administrative
$181.7M$182.8M$227.3M$249.7M$236.7M
General & Administrative Expenses
$181.7M$182.8M$227.3M$249.7M$236.7M
Salaries & Wages
$5.4M$2.4M$2.2M$2.4M$2.3M
Depreciation & Amortization
$23.1M$23.0M$5.7M----
Depreciation & Amortization
$23.1M$23.0M$5.7M----
Amortization
$23.1M$23.0M$5.7M$20.5M$19.6M
Other Operating Expenses
$65.1M--------
OPERATING INCOME
Operating income
$1.6B$1.4B$307.1M$1.5B$1.3B
EBITDA
$1.9B$1.4B$418.0M$1.7B$1.3B
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$157.1M$166.1M$188.0M$187.2M--
Intinc
------$72.3M$47.3M
Net Non-Operating Interest Income/Expense
$-157.1M$-619.0M$109.6M$-488.4M$-685.1M
Gain on Sale of Securities
$-13.7M$32.0M$174.9M$-2.3M$-6.0M
Other Income/Expense
$-263.6M$23.4M$-583.2M$-322.8M$-216.5M
Other Special Charges
$-32.8M$-5.7M$-14.8M$-21.7M$-1.5M
SPECIAL ITEMS
Special Income Charges
$-74.7M$-4.5M$-615.8M$-20.9M$-1.1M
Impairment of Capital Assets
$65.1M--$615.8M----
PRE-TAX INCOME
EBIT
$1.9B$1.4B$418.0M$1.7B$1.3B
Pre-Tax Income
$1.7B$1.2B$230.1M$1.7B$1.3B
NET INCOME
Net Income
$975.0M$619.7M$42.8M$1.1B$859.0M
Net Income (Continuing Operations)
$975.0M$619.7M$230.1M$1.7B$1.3B
Net Income (Discontinued Operations)
$975.0M$619.7M$42.8M$1.1B$859.0M
Net Income (Common Stockholders)
$495.2M$619.7M$42.8M$1.1B$859.0M
Normalized Income
$1.4B------$1.3B
TOTALS
Total Expenses
$296.1M$405.9M$1.3B$301.7M$238.7M
SHARE & EPS DATA
Average Shares Outstanding
$375.4M$414.8M$438.0M$447.6M$448.2M
Average Shares Outstanding (Diluted)
$375.5M$414.8M$438.0M$602.9M$594.1M
Shares Outstanding
$607.1M$607.2M$607.2M$597.4M$576.5M
Basic EPS
$1.32$1.49$0.10$2.54$1.92
Basic EPS (Continuing Operations)
$1.32$1.49$0.10$2.54$1.92
Diluted EPS
$1.32$1.49$0.10$2.53$1.91
Diluted EPS (Continuing Operations)
$1.32$1.49$0.10$2.53$1.91
Dividend Per Share
$0.60$0.68$0.76$0.80$0.84
OTHER METRICS
Earnings from equity interest
$44.5M$-19.5M$-9.0M$28.9M$29.6M
Earnings From Equity Interest Net Of Tax
$44.5M$-19.5M$-9.0M$28.9M$29.6M
Minority Interests
$-726.9M$-621.5M$-187.2M$-565.3M$-471.8M
Net Income Discontinuous Operations
$-230.8M$-452.8M------
Other Gand A
$181.7M$182.8M$227.3M$249.7M$236.7M
Provision For Gain Loss On Disposal
$-230.8M$-452.8M------
Othspecchg
$9.6M$4.5M$11.1M$20.9M$1.1M

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2RPRX$35.98+1.0%2.99M
3
4
5
6

Get Royalty Pharma plc Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.